1. Introduction {#sec1-medicines-04-00047}
===============

Sage (also known as garden sage, common sage, or culinary sage; *Salvia officinalis* L., Lamiaceae) is a popular culinary and medicinal herb, native to southern Europe and the Mediterranean, but now cultivated worldwide. The plant has been used since ancient times for various human ailments. For example, in England, a decoction of sage leaves with wine was gargled to relieve toothache \[[@B1-medicines-04-00047]\]; in Germany, sage was used orally for gastrointestinal problems and excessive perspiration, and was used topically for inflammation of the mucous membranes of the mouth and throat \[[@B2-medicines-04-00047]\]; the Cherokee Native Americans have used an infusion of the plant to treat colds and coughs, and as an antidiarrheal \[[@B3-medicines-04-00047]\]. Commercial sage oil is generally characterized by thujones, with α-thujone usually predominating (18--43%) over β-thujone (3--8.5%), camphor (4.5--24.5%), 1,8-cineole (5.5--13%), α-humulene (0--12%), α-pinene (1--6.5%), camphene (1.5--7%), and bornyl acetate (2.5% maximum) \[[@B2-medicines-04-00047]\].

Caution should be exercised in using sage essential oil. The oil contains large concentrations of α-thujone, which was thought to have been the hallucinogenic constituent of absinthe and the cause of absinthism. This, however, has been shown to be false \[[@B4-medicines-04-00047]\]. Nevertheless, high doses of α-thujone causes convulsions by way of blocking γ-aminobutyric acid (GABA)-gated chloride channels \[[@B5-medicines-04-00047],[@B6-medicines-04-00047]\], and chronic exposure can lead to neurotoxicity \[[@B7-medicines-04-00047],[@B8-medicines-04-00047]\] and carcinogenicity \[[@B9-medicines-04-00047]\]. Use of the herb itself is safe, however; it has been estimated that between 2 and 20 cups of sage tea would be required to reach the acceptable daily intake of thujone \[[@B10-medicines-04-00047]\]. Additionally, thujone has shown a low affinity for cannabinoid receptors, but failed to show cannabinoid receptor agonism \[[@B11-medicines-04-00047]\]. α-Thujone has also been shown to reduce 5-HT~3~ (ligand-gated ion channel serotonin) receptor activity \[[@B12-medicines-04-00047]\]. In this work, we have characterized two commercial sage essential oils as well as an essential oil obtained by hydrodistillation of sage leaves grown in Mexico. In addition, a cluster analysis has been carried out to place the different chemotypes of sage oil in perspective.

2. Materials and Methods {#sec2-medicines-04-00047}
========================

2.1. Essential Oils {#sec2dot1-medicines-04-00047}
-------------------

Fresh sage (*Salvia officinalis*, Jacobs Farm organic sage, Pescadero, CA, USA, grown in Mexico) was purchased from a local market in Huntsville, Alabama on 8 April 2017. The fresh leaves (34.64 g) were chopped and hydrodistilled using a Likens--Nickerson apparatus for 4 h with continuous extraction with dichloromethane (CH~2~Cl~2~) to give 1.653 g yellow essential oil. Commercial sage leaf essential oils were obtained from Mountain Rose Herbs (Eugene, OR; oil from California) and Selikaj Ltd. (Koplik, Albania).

2.2. Gas Chromatography-Mass Spectrometry {#sec2dot2-medicines-04-00047}
-----------------------------------------

The leaf essential oil samples of *Salvia officinalis* were analyzed by GC-MS using an Agilent 6890 gas chromatograph coupled to an Agilent 5973 mass selective detector (MSD), operated in the electron impact mode with electron energy = 70 eV, a scan range of 40--400 amu, a scan rate of 3.99 scans/sec, and operated through an Agilent ChemStation data system. The GC column was an HP-5 ms fused silica capillary column with a (5% phenyl)-polydimethylsiloxane stationary phase, a film thickness of 0.25 μm, a length of 30 m, and an internal diameter of 0.25 mm. The carrier gas was helium with a column head pressure of 92.4 kPa and a flow rate of 1.5 mL/min. The inlet temperature was 250 °C and the interface temperature was 280 °C. The GC oven temperature was programmed, 60 °C initial temperature, which was held for 5 min, temperature increased at a rate of 3 °C/min up to 280 °C. Solutions of essential oils (1% in CH~2~Cl~2~) were prepared and 1-μL injections were carried out using a splitless mode. Identification of the oil components was based on their retention indices determined by reference to a homologous series of *n*-alkanes, and by comparison of their mass spectral fragmentation patterns with those reported in the literature \[[@B13-medicines-04-00047]\], and stored in our in-house MS library.

2.3. Quantitative Gas Chromatography {#sec2dot3-medicines-04-00047}
------------------------------------

Quantitative GC was carried out using an Agilent 6890 GC with Agilent flame ionization detector (FID), HP-5ms column, helium carrier gas (head pressure = 144.1 kPa, flow rate = 2.0 mL/min), same oven temperature program as GC-MS (above). The percentages of each component in the essential oils are reported as raw percentages without standardization.

2.4. Hierarchical Cluster Analysis {#sec2dot4-medicines-04-00047}
----------------------------------

A total of 185 *S. officinalis* leaf essential oil compositions from the published literature \[[@B14-medicines-04-00047],[@B15-medicines-04-00047],[@B16-medicines-04-00047],[@B17-medicines-04-00047],[@B18-medicines-04-00047],[@B19-medicines-04-00047],[@B20-medicines-04-00047],[@B21-medicines-04-00047],[@B22-medicines-04-00047],[@B23-medicines-04-00047],[@B24-medicines-04-00047],[@B25-medicines-04-00047],[@B26-medicines-04-00047],[@B27-medicines-04-00047],[@B28-medicines-04-00047],[@B29-medicines-04-00047],[@B30-medicines-04-00047],[@B31-medicines-04-00047],[@B32-medicines-04-00047],[@B33-medicines-04-00047],[@B34-medicines-04-00047],[@B35-medicines-04-00047],[@B36-medicines-04-00047],[@B37-medicines-04-00047],[@B38-medicines-04-00047],[@B39-medicines-04-00047],[@B40-medicines-04-00047],[@B41-medicines-04-00047],[@B42-medicines-04-00047],[@B43-medicines-04-00047],[@B44-medicines-04-00047],[@B45-medicines-04-00047],[@B46-medicines-04-00047],[@B47-medicines-04-00047],[@B48-medicines-04-00047],[@B49-medicines-04-00047],[@B50-medicines-04-00047],[@B51-medicines-04-00047],[@B52-medicines-04-00047],[@B53-medicines-04-00047],[@B54-medicines-04-00047],[@B55-medicines-04-00047],[@B56-medicines-04-00047],[@B57-medicines-04-00047],[@B58-medicines-04-00047],[@B59-medicines-04-00047],[@B60-medicines-04-00047],[@B61-medicines-04-00047],[@B62-medicines-04-00047],[@B63-medicines-04-00047],[@B64-medicines-04-00047],[@B65-medicines-04-00047],[@B66-medicines-04-00047]\], as well as the three compositions from this study were treated as operational taxonomic units (OTUs). The percentage composition of 26 major essential oil components (α-pinene, camphene β-pinene, myrcene, α-phellandrene, *p*-cymene, limonene, 1,8-cineole, (*E*)-β-ocimene, γ-terpinene, α-thujone, β-thujone, camphor, borneol, α-terpineol, bornyl acetate, α-terpinyl acetate, β-caryophyllene, aromadendrene, α-humulene, viridiflorene, viridiflorol, humulene epoxide II, pimaradiene, manool, and sclareol) was used to determine the compositional associations of the various *S. officinalis* essential oil samples by agglomerative hierarchical cluster (AHC) analysis using the XLSTAT software, version 2015.4.01. Pearson correlation was selected as a measure of similarity, and the unweighted pair-group method with arithmetic average (UPGMA) was used for cluster definition.

3. Results and Discussion {#sec3-medicines-04-00047}
=========================

The sage leaf essential oil compositions are summarized in [Table 1](#medicines-04-00047-t001){ref-type="table"}. The sage oils were qualitatively similar and dominated by the monoterpenoids α-thujone (17--27%), 1,8-cineole (12--27%), and camphor (13--21%), with lesser amounts of β-thujone (3.8--6.0%), camphene (3.5--5.3%), and the sesquiterpene α-humulene (3.1--4.4%). This chemical profile is similar to many sage oil descriptions previously reported \[[@B15-medicines-04-00047],[@B17-medicines-04-00047],[@B18-medicines-04-00047],[@B19-medicines-04-00047],[@B20-medicines-04-00047],[@B22-medicines-04-00047],[@B24-medicines-04-00047],[@B25-medicines-04-00047],[@B26-medicines-04-00047],[@B27-medicines-04-00047],[@B28-medicines-04-00047],[@B29-medicines-04-00047],[@B30-medicines-04-00047],[@B31-medicines-04-00047],[@B32-medicines-04-00047],[@B33-medicines-04-00047],[@B37-medicines-04-00047],[@B39-medicines-04-00047],[@B40-medicines-04-00047],[@B41-medicines-04-00047],[@B42-medicines-04-00047],[@B44-medicines-04-00047],[@B45-medicines-04-00047],[@B47-medicines-04-00047],[@B49-medicines-04-00047],[@B51-medicines-04-00047],[@B52-medicines-04-00047],[@B53-medicines-04-00047],[@B55-medicines-04-00047],[@B57-medicines-04-00047],[@B58-medicines-04-00047],[@B60-medicines-04-00047],[@B61-medicines-04-00047],[@B63-medicines-04-00047],[@B64-medicines-04-00047],[@B65-medicines-04-00047],[@B67-medicines-04-00047]\], yet notably different from many others \[[@B14-medicines-04-00047],[@B25-medicines-04-00047],[@B26-medicines-04-00047],[@B34-medicines-04-00047],[@B37-medicines-04-00047],[@B38-medicines-04-00047],[@B41-medicines-04-00047],[@B46-medicines-04-00047],[@B54-medicines-04-00047],[@B56-medicines-04-00047]\]. This prompted us to undertake a hierarchical cluster analysis of *S. officinalis* leaf oil compositions in order to describe the various chemotypes of this herb.

Tucker and Maciarello described five groups based on four principal constituents: (1) camphor \> α-thujone \> 1,8-cineole \> β-thujone; (2) camphor \> α-thujone \> β-thujone \> 1,8-cineole; (3) β-thujone \> camphor \> 1,8-cineole \> α-thujone; (4) 1,8-cineole \> camphor \> α-thujone \> β-thujone; and (5) α-thujone \> camphor \> β-thujone \> 1,8-cineole \[[@B61-medicines-04-00047]\]. Unfortunately, while these four principal constituents describe many *S. officinalis* essential oils, there are other samples that are rich in α-humulene \[[@B41-medicines-04-00047],[@B56-medicines-04-00047]\], viridiflorol \[[@B26-medicines-04-00047],[@B34-medicines-04-00047]\], manool \[[@B34-medicines-04-00047],[@B66-medicines-04-00047]\], or sclareol \[[@B54-medicines-04-00047]\].

Jug-Dujaković and co-workers examined the essential oil compositions of 25 indigenous populations of *S. officinalis* growing in the Dalmatian region of Croatia \[[@B37-medicines-04-00047]\]. These workers carried out a hierarchical cluster analysis based on eight principal components (α-thujone, camphor, β-thujone, 1,8-cineole, β-pinene, camphene, borneol, and bornyl acetate), and were able to delineate three chemotypes of Dalmatian sage from Dalmatia: (A) α-thujone \> camphor \> 1,8-cineole \> β-thujone; (B) β-thujone \> α-thujone \> camphor ≈ 1,8-cineole; and (C) camphor \> α-thujone \> 1,8-cineole \> camphene ≈ borneol.

Lakušić and co-workers analyzed *S. officinalis* essential oils in various stages of development \[[@B41-medicines-04-00047]\]. These workers sampled two different individual plants from different geographical origin, but grown in a common garden under identical conditions. Young leaves were characterized with high concentrations of α-humulene, viridiflorol, and manool, but low concentrations of camphor or α-thujone. As leaves aged, the concentrations of α-humulene, viridiflorol, and manool dropped significantly with concomitant increases in camphor and α-thujone. A hierarchical cluster analysis showed that young leaves belonged to an α-humulene chemotype, while old leaves from the plant originating in Serbia belonged to a camphor chemotype, and old leaves from the plant originating in Croatia belonged to a thujone chemotype.

In this current work, we have carried out a hierarchical cluster analysis of 188 *S. officinalis* leaf essential oil compositions; the three chemical compositions presented above in conjunction with 185 analyses from the literature. A total of 26 components were used in the analysis. Based on the cluster analysis of the volatile compositions, there are five major chemotypes of *Salvia officinalis*: C1--C5 (see [Figure 1](#medicines-04-00047-f001){ref-type="fig"}).

The most populated chemotype, C1, is an α-thujone/camphor chemotype and represents "typical" sage oil. The C1 cluster can be further subdivided ([Figure 2](#medicines-04-00047-f002){ref-type="fig"}) into three distinct subgroups: C1a, camphor \> α-thujone \> β-pinene, which is equivalent to group 1 described by Tucker and Maciarello \[[@B61-medicines-04-00047]\], type C described by Jug-Dujaković et al. \[[@B37-medicines-04-00047]\], and type IIb described by Lakušić and co-workers \[[@B41-medicines-04-00047]\]; C1b, α-thujone ≈ camphor \> sclareol; and C1c, α-thujone \> camphor \> 1,8-cineole, which is equivalent to Tucker and Maciarello type 5 \[[@B61-medicines-04-00047]\], Jug-Dujaković et al. type A \[[@B37-medicines-04-00047]\], and Lakušić et al. type IIa \[[@B41-medicines-04-00047]\]. Chemotype C1c averages 28.0% α-thujone, 18.6% camphor, 10.5% 1,8-cineole, and 6.4% β-thujone, and represents the "best overall" composition of sage oil \[[@B2-medicines-04-00047],[@B61-medicines-04-00047]\]. It is noteworthy that type C1c is also represented by samples from the Dalmatian region of the Balkan Peninsula \[[@B26-medicines-04-00047],[@B37-medicines-04-00047],[@B41-medicines-04-00047]\], as well as commercial samples from Europe \[[@B52-medicines-04-00047]\] and Albania, Mexico, and California from this study.

The α-humulene-rich chemotype, C2, is equivalent to type I that was described by Lakušić and co-workers \[[@B41-medicines-04-00047]\]. This chemotype can be subdivided ([Figure 3](#medicines-04-00047-f003){ref-type="fig"}) into three subgroups: C2a, α-humulene \> α-thujone \> camphor; C2b, 1,8-cineole ≈ α-thujone \> α-humulene; and C2c, viridiflorol \> manool ≈ α-thujone \> α-humulene. Lakušić and co-workers had observed α-humulene concentrations to be relatively high in young leaves collected in April and May, with decreasing concentrations during late summer (August--October), and then increasing again in the autumn and winter \[[@B41-medicines-04-00047]\]. Samples from other global locations, however, showed high α-humulene concentrations during the summer \[[@B26-medicines-04-00047],[@B48-medicines-04-00047],[@B56-medicines-04-00047]\], and likely, then, represents a real chemotype.

The β-thujone-rich chemotype, C3, is equivalent to Tucker and Maciarello type 3 \[[@B61-medicines-04-00047]\] and Jug-Dujaković et al. type B \[[@B37-medicines-04-00047]\]. Chemotype C3 can be subdivided into two subroups ([Figure 4](#medicines-04-00047-f004){ref-type="fig"}): C3a, β-thujone \> camphor ≈ α-thujone ≈ 1,8-cineole, and C3b, camphor \> β-thujone \> 1,8-cineole. Type C4, a 1,8-cineole/camphor chemotype, is equivalent to Tucker and Maciarello type 4 \[[@B61-medicines-04-00047]\], and shows two subtypes: C4a, 1,8-cineole ≈ camphor, and C4b, 1,8-cineole \>\> camphor ([Figure 5](#medicines-04-00047-f005){ref-type="fig"}). Chemotype C5 ([Figure 6](#medicines-04-00047-f006){ref-type="fig"}) is a sclareol/α-thujone type.

Although C1 (thujone/camphor) is the major chemotype of *S. officinalis*, there are several other chemotypes and this should have a profound effect on the flavor and fragrance profile of the herb as well as any potential biological activities and medicinal uses. The overall fragrance description and the fragrance descriptions of the components of C1c type sage oils have been reported \[[@B30-medicines-04-00047],[@B67-medicines-04-00047]\]. A perusal of the literature has not revealed any flavor or fragrance descriptions of the other sage oil chemotypes, however. Similarly, most bioactivity studies have been carried out on C1 chemotype sage oils. Savalev and co-workers have examined the butyryl- and acetyl-cholinesterase inhibitory activities of type C2a sage oils \[[@B56-medicines-04-00047]\]; Lima and co-workers examined the cytotoxicity of a C2b type sage oil on rat hepatocytes \[[@B43-medicines-04-00047]\]; and Abu-Darwish and co-workers carried out antifungal studies with chemotype C4b sage oils \[[@B14-medicines-04-00047]\]. However, no C1c type sage oils were included in these studies for comparison. Russo and co-workers examined the cytotoxic activities on three different tumor cell lines of two different chemotypes of sage oil, C1b and C5 chemotypes, but there were no correlations between sage oil chemical compositions and cytotoxicities \[[@B54-medicines-04-00047]\].

4. Conclusions {#sec4-medicines-04-00047}
==============

This study has revealed the presence of five major chemotypes of sage (*Salvia officinalis*) leaf essential oils, with several subtypes. Most sage oils belonged to the "typical", α-thujone \> camphor \> 1,8-cineole, chemotype, but the essential oil compositions can vary widely and may have a profound effect on flavor and fragrance profiles as well as biological activities. It would be interesting to see if there exist differences in fragrance descriptions or in biological activities for the different chemotypes of sage essential oils.

W.N.S. conceived and designed the experiments; J.D.C. and P.S. performed the experiments; all authors analyzed the data; W.N.S. wrote the paper.
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medicines-04-00047-t001_Table 1

###### 

Chemical compositions of leaf essential oil of *Salvia officinalis* from three different global locations.

  RI ^a^   RI ^b^   Compound                             Percent Composition ^c^          
  -------- -------- ------------------------------------ ------------------------- ------ ------
  847      856      (*Z*)-Salvene                        0.2                       0.3    0.3
  855      866      (*E*)-Salvene                        tr ^g^                    tr     0.1
  921      926      Tricyclene                           0.2                       0.1    0.2
  926      930      α-Thujene                            0.3                       0.5    0.5
  932      939      α-Pinene                             5.0                       2.4    5.2
  945      954      Camphene                             5.2                       3.5    5.3
  973      975      Sabinene                             0.1                       0.6    \-
  980      979      β-Pinene                             4.1                       2.6    1.3
  981      979      1-Octen-3-ol                         tr                        0.1    0.1
  989      990      Myrcene                              2.8                       4.5    1.2
  1000     1002     α-Phellandrene                       0.1                       tr     \-
  1018     1017     α-Terpinene                          0.5                       tr     0.2
  1022     1024     *p*-Cymene                           0.6                       0.2    1.3
  1029     1029     Limonene                             1.5                       1.4    2.2
  1034     1031     1,8-Cineole                          26.9                      15.5   11.9
  1038     1037     (*Z*)-β-Ocimene                      0.1                       0.1    \-
  1042     1042     Benzene acetaldehyde                 \-                        tr     \-
  1049     1050     (*E*)-β-Ocimene                      \-                        tr     \-
  1059     1059     γ-Terpinene                          0.7                       0.7    0.4
  1070     1070     *cis*-Sabinene hydrate               0.1                       0.4    \-
  1086     1088     Terpinolene                          0.2                       0.2    0.3
  1090     1091     *p*-Cymenene                         tr                        \-     \-
  1100     1096     Linalool                             0.3                       tr     0.3
  1103     1098     *trans*-Sabinene hydrate             \-                        0.4    \-
  1108     1102     α-Thujone                            17.2                      18.8   27.4
  1118     1114     β-Thujone                            3.8                       4.4    6.0
  1122     1127     Chrysanthenone                       tr                        \-     \-
  1137     1138     3-*iso*-Thujanol                     tr                        \-     \-
  1147     1146     Camphor                              12.8                      14.9   21.4
  1149     1151     *neo-iso*-3-Thujanol                 tr                        \-     \-
  1161     1162     *trans*-Pinocamphone                 0.1                       \-     \-
  1168     1168     3-Thujanol                           0.2                       \-     \-
  1169     1169     Borneol                              1.2                       1.0    1.7
  1170     1166     δ-Terpineol                          0.4                       0.2    \-
  1180     1177     Terpinen-4-ol                        0.5                       0.6    0.4
  1186     1188     α-Terpineol                          1.1                       0.4    0.4
  1236     1237     Ascaridole                           \-                        0.2    \-
  1254     1257     Linalyl acetate                      0.2                       \-     \-
  1286     1288     Bornyl acetate                       1.1                       0.5    1.8
  1294     1290     *trans*-Sabinyl acetate              0.1                       tr     0.2
  1337     1320     2,3-Pinanediol                       tr                        \-     \-
  1346     1249     α-Terpinyl acetate                   0.6                       \-     \-
  1375     1376     α-Copaene                            0.1                       \-     \-
  1419     1419     β-Caryophyllene                      4.9                       3.4    3.5
  1432     \-\--    6-Oxobornyl acetate                  tr                        \-     \-
  1434     1433     α-Maaliene                           0.1                       \-     \-
  1439     1441     Aromadendrene                        0.4                       0.2    \-
  1446     1444     Myltayl-4(12)-ene                    tr                        \-     \-
  1448     \-\--    5-Oxobornyl acetate                  0.1                       \-     \-
  1453     1454     α-Humulene                           3.1                       5.7    4.4
  1460     1460     *allo*-Aromadendrene                 \-                        0.1    0.1
  1467     1466     9-*epi*-β-Caryophyllene              0.1                       \-     \-
  1476     1476     *trans*-Cadina 1(6)-4-diene          0.1                       \-     \-
  1482     1485     Germacrene D                         \-                        0.1    \-
  1487     1483     Guaia-1(10)-11-diene                 0.1                       \-     \-
  1496     1496     Viridiflorene                        0.3                       \-     0.2
  1497     1500     Bicyclogermacrene                    \-                        0.1    \-
  1511     1523     δ-Amorphene                          0.1                       \-     \-
  1517     1523     δ-Cadinene                           0.1                       \-     \-
  1579     1578     Spathulenol                          \-                        0.1    \-
  1583     1583     Caryophyllene oxide                  0.1                       0.2    \-
  1591     1592     Viridiflorol                         2.0                       7.4    1.5
  1609     1608     Humulene epoxide II                  0.2                       0.3    0.2
  1636     1640     Caryophylla-4(12),8(13)-dien-5α-ol   0.1                       \-     \-
  2056     2057     Manool                               0.2                       8.2    \-
                    Monoterpene Hydrocarbons             21.5                      17.0   18.5
                    Oxygenated Monoterpenoids            66.5                      57.3   71.5
                    Sesquiterpene Hydrocarbons           9.4                       9.5    8.2
                    Oxygenated Sesquiterpenoids          2.4                       8.0    1.7
                    Others                               0.2                       8.2    0.1
                    Total Identified                     100                       100    100

^a^ RI = Retention index determined with respect to a homologous series of *n*-alkanes on a HP-5ms column. ^b^ Literature \[[@B13-medicines-04-00047]\] Retention indices. ^c^ Percent composition based on peak integration without standardization. ^d^ Commercial sage leaf oil (Selikaj Ltd., Koplik, Albania). ^e^ Leaf essential oil from fresh sage (Jacobs Farm, Pescadero, California, grown in Mexico). ^f^ Commercial sage leaf oil (Mountain Rose Herbs, Eugene, Oregon, oil from California). ^g^ tr = trace (\<0.05%).
